Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rastetter, Mary"'
Autor:
Hackman, Robert C., Myerson, David, Meyers, Joel D., Shulman, Howard M., Sale, George E., Goldstein, Lynn C., Rastetter, Mary, Flournoy, Nancy, Thomas, E. Donnall
Publikováno v:
The Journal of Infectious Diseases, 1985 Feb 01. 151(2), 325-329.
Externí odkaz:
https://www.jstor.org/stable/30109791
Publikováno v:
Cancer Immunology, Immunotherapy; Aug2013, Vol. 62 Issue 8, p1335-1345, 11p
Publikováno v:
Cancer Research. 77:3687-3687
Bexarotene is an oral rexinoic receptor (RXR) agonist that has anti-proliferative activity in breast cancer. RXRs are nuclear receptors that heterodimerize, including with the retinoic acid receptor (RAR), to activate transcription for processes incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afb11710e88f61c138cd017d87f9a161
https://doi.org/10.1158/1538-7445.am2017-3687
https://doi.org/10.1158/1538-7445.am2017-3687
Publikováno v:
Cancer Research. 75:279-279
In breast cancer, increased immune infiltrate prior to neoadjuvant chemotherapy predicts improved pathologic complete response (pCR) and improved survival, however almost half of breast tumors have no CD8+ T cell infiltrate. Evidence has emerged that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68beb88ec66dda7a08638ab4d39b8084
https://doi.org/10.1158/1538-7445.am2015-279
https://doi.org/10.1158/1538-7445.am2015-279
Publikováno v:
Cancer Research. 75:P5-04
The tumor immune environment is important in breast cancer with greater than 50% immune infiltrate (LPBC) prior to neoadjuvant chemotherapy predicting improved pathologic complete response, and LPBC and CD8 infiltrate prior to adjuvant therapy predic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5a661efbb3f50f99eb0bba5d23aae69
https://doi.org/10.1158/1538-7445.sabcs14-p5-04-06
https://doi.org/10.1158/1538-7445.sabcs14-p5-04-06